Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,356,712,224
+$105,681,799 QoQ
Shares Held
18,340,173
-2.0% QoQ
Ownership
0.743%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#21
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 1%
None 10%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. MRK ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,356,712,224 | 18,340,173 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,251,030,425 | 18,713,363 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,017,257,998 | 19,164,526 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,829,200,122 | 21,794,354 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,741,316,550 | 21,997,430 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,076,225,714 | 23,130,857 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,408,762,653 | 24,213,537 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,119,337,680 | 18,662,713 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,371,053,494 | 19,152,290 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,591,885,796 | 19,642,939 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $2,270,878,523 | 20,829,926 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,572,963,145 | 24,992,357 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,082,909,468 | 26,717,302 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,101,159,759 | 29,148,978 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,372,395,028 | 30,395,629 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,673,958,041 | 31,049,211 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,970,361,898 | 32,580,475 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,690,626,913 | 32,792,528 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,373,574,821 | 30,970,444 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,203,283,192 | 29,334,086 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,303,571,112 | 29,620,305 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,356,683,269 | 30,570,528 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $2,602,152,854 | 31,811,174 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,722,954,700 | 32,826,443 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,440,835,895 | 31,563,880 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,679,052,833 | 34,820,041 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||